Veritas, Khaitan lead on Recipharm’s acquisition of stake in Nitin Lifesciences for 671 crore

Bar & Bench October 21 2015

Swedish firm Recipharm has picked up 74 per cent stake in sterile injectables maker Nitin Lifesciences for Rs. 671 crore ($103 million) in an all cash deal.

Veritas Legal acted for Recipharm with a team led by Partner Nandish Vyas along with Associates Natasha Sethna and Tejasvi Saxena.

Khaitan & Co advised the promoters of Nitin Lifesciences with a team led by Partner Kalpana Unadkat along with Senior Associate Shweta Dwivedi and Associate Bidya Mohanty.

Khaitan Partner . . .

You need to have an active subscription to view this content.